Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Speed of a Transverse Wave01:13

Speed of a Transverse Wave

3.9K
The speed of a wave depends on the characteristics of the medium. For example, in the case of a guitar, the strings vibrate to produce the sound. The speed of the waves on the strings and the wavelength determine the frequency of the sound produced. The strings on a guitar have different thicknesses but may be made of similar material. They have different linear densities, and the linear density is defined as the mass per length.
One of the key properties of any wave is the wave speed. Light...
3.9K
Speed of Sound in Gases01:08

Speed of Sound in Gases

4.0K
The speed of sound in a gaseous medium depends on various factors. Since gases constitute molecules that are free to move, they are highly compressible. Hence, sound waves travel slowly through gases. Thermodynamics helps us understand the relationship between pressure, volume, and temperature of gases, thus, the speed of sound in an ideal gas can be determined using the laws of thermodynamics. At the same time, Newton's laws of motion and the continuity equation of fluid dynamics also come...
4.0K
Distribution of Molecular Speeds01:27

Distribution of Molecular Speeds

5.4K
The motion of molecules in a gas is random in magnitude and direction for individual molecules, but a gas of many molecules has a predictable distribution of molecular speeds. This predictable distribution of molecular speeds is known as the Maxwell-Boltzmann distribution. The distribution of molecular speeds in liquids is comparable to that of gases but not identical and can help to understand the phenomenon of the boiling and vapor pressure of a liquid. Consider that a molecule requires a...
5.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Drag Force and Terminal Speed01:18

Drag Force and Terminal Speed

3.3K
An interesting force in everyday life is the force of drag on an object when it is moving in a fluid. Like friction, the drag force always opposes the motion of an object. Unlike simple friction, the drag force is proportional to some function of the velocity of the object in that fluid. This functionality is complicated and depends upon the shape of the object, its size, its velocity, and the fluid it is in. For most large objects, such as cyclists, cars, and baseballs, that are not moving too...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced Cost.

Transplantation and cellular therapy·2026
Same author

Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphoma.

bioRxiv : the preprint server for biology·2025
Same author

Synthetic gene circuits drive disease-fighting T cells.

Science (New York, N.Y.)·2024
Same author

Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia.

Blood·2023
Same author

The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.

Journal of translational medicine·2023
Same author

Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma.

Leukemia & lymphoma·2023

Related Experiment Video

Updated: Jan 23, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K

CAR T-cell therapy: Full speed ahead.

David Sermer1, Renier Brentjens1

  • 1Cellular Therapeutics Center, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Hematological Oncology
|June 13, 2019
PubMed
Summary

Chimeric antigen receptor (CAR) T-cell therapy shows promise for blood cancers like diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukemia (ALL). This review covers current trials, novel designs, and challenges like resistance and toxicity.

More Related Videos

A Spheroid Killing Assay by CAR T Cells
08:19

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

17.2K
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:14

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

813

Related Experiment Videos

Last Updated: Jan 23, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K
A Spheroid Killing Assay by CAR T Cells
08:19

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

17.2K
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:14

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

813

Area of Science:

  • Immunotherapy
  • Oncology
  • Cellular Therapy

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy has revolutionized lymphoid malignancy treatment, particularly for diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukemia (ALL).
  • Despite successes, significant limitations persist, including incomplete or non-durable responses and severe toxicities in some patients.
  • Expanding CAR T-cell therapy to new indications remains a critical objective.

Purpose of the Study:

  • To review landmark trials of anti-CD19 CAR T cells and early-phase trials of novel CAR constructs.
  • To discuss innovative CAR designs currently in preclinical development.
  • To address challenges of CAR T-cell toxicity, resistance, and failure, and explore future therapeutic strategies.

Main Methods:

  • Literature review of published clinical trials and preclinical research.
  • Analysis of data from landmark anti-CD19 CAR T-cell studies.
  • Discussion of emerging CAR T-cell technologies and resistance mechanisms.

Main Results:

  • Anti-CD19 CAR T-cell therapy has demonstrated significant efficacy in DLBCL and ALL.
  • Novel CAR designs and targets are under investigation for broader applicability.
  • Understanding of CAR T-cell resistance and toxicity mechanisms is evolving.

Conclusions:

  • CAR T-cell therapy represents a major advancement in treating lymphoid malignancies.
  • Ongoing research focuses on improving efficacy, expanding indications, and mitigating toxicity.
  • Future directions include novel CAR designs and strategies to overcome treatment resistance.